Safety and efficacy of gatifloxacin in community-a...[Diagn Microbiol Infect Dis. 2002] - PubMed Result

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: Diagn Microbiol Infect Dis. 2002 Sep;44(1):65-7. Links

Safety and efficacy of gatifloxacin in community-acquired pneumonia: rationale for the Tequin Clinical Experience Study (TeqCES).

Mandell LA.

McMaster University, Hamilton, Ontario, Canada. lmandell@mcmaster.ca

PMID: 12376034 [PubMed - indexed for MEDLINE]

Related articles

Implications of TeqCES: efficacy and safety of gatifloxacin in community-acquired pneumonia.
Diagn Microbiol Infect Dis. 2002 Sep; 44(1):127-8.

[Diagn Microbiol Infect Dis. 2002]
Oral gatifloxacin in outpatient community-acquired pneumonia: results from TeqCES, a community-based, open-label, multicenter study.
Diagn Microbiol Infect Dis. 2002 Sep; 44(1):85-91.

[Diagn Microbiol Infect Dis. 2002]
Efficacy and safety of gatifloxacin in elderly outpatients with community-acquired pneumonia.
Diagn Microbiol Infect Dis. 2002 Sep; 44(1):117-25.

[Diagn Microbiol Infect Dis. 2002]
ReviewRole of levofloxacin in the treatment of lower respiratory tract infections (LRTIs).
J Chemother. 2004 Apr; 16 Suppl 2:11-4.

[J Chemother. 2004]
ReviewFluoroquinolones for the treatment of outpatient community-acquired pneumonia.
Diagn Microbiol Infect Dis. 2002 Sep; 44(1):69-76.

[Diagn Microbiol Infect Dis. 2002]
» See reviews... | » See all...

Recent Activity

Clear Turn Off Turn On

Safety and efficacy of gatifloxacin in community-acquired pneumonia: rationale for the Teq...Safety and efficacy of gatifloxacin in community-acquired pneumonia: rationale for the Tequin Clinical Experience Study (TeqCES).

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show